SUGGESTED PRESCRIBED DOSAGE LIST

Similar documents
Recent initiatives of the FANC. Michel Biernaux Health Protection Service Health and Environment Department

Contrast Agents and Radiopharmaceuticals 2017

2017 St. Luke's-Roosevelt Nuclear Medicine Department Procedure Catalog. meds

Radiopharmaceutical Activities Administered for Diagnostic and Therapeutic Procedures in Nuclear Medicine in Argentine: Results of a National Survey

NUCLEAR MEDICINE IN VIVO

Official Listing of Radioactive Materials Approved for the Four Groups of Diagnostic Uses as Defined in 15A NCAC

NUCLEAR MEDICINE APC TASK FORCE

RadTool Nuclear Medicine Flash Facts

Overview Therapeutic Radiopharmaceuticals in Nuclear Medicine Definition: Characteristics of the Ideal Therapeutic Radiopharmaceutical

RADIOPHARMACEUTICALS AND DRUGS ELIGIBLE FOR CONTINUED SEPARATE MEDICARE PAYMENT ( 2 TO 3 Year Transitional Period )

Contributions of Nuclear Isotopes in Medicine, a Perspective

Sacred Heart Hospital on the Emerald Coast

Deleted Effective Beginning of Calendar Year Not Paid under Outpatient PPS Not Paid Under OPPS or any other Medicare payment system

Department of Nuclear Medicine with Positron Emission Tomography

Radionuclide Therapy: History, Present and Future Promise. History of Radionuclide (RN) Therapy. History of RN Therapy 8/2/2017

Not Paid under Outpatient PPS. Deleted Effective Beginning of Calendar Year Not Paid under Outpatient PPS

Steven G. Marsh MS, DABMP, Medical Health Physics RSO - Baystate Health Springfield, MA

Release of Patients or Human Research Subjects Administered Radioactive Materials

Excretion Factors: the percentage of administered radioactivity released to sewer for routinely used radiopharmaceuticals.

HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST

Dr Alfred O Ankrah FCNP

HIP RADIOLOGY PROGRAM CODE LISTS

Nuclear Medicine in Australia. Shaun Jenkinson

Health Concerns Related to Radiation Exposure. of the Female Nuclear Medicine Patient. Michael G. Stabin

Water Any Inulin IV Normal renal function Inulin IV Abnormal renal function Glucose IV Normal Carfentanil IV 17.

Radionuclid Therapy. dr. Erzsébet Schmidt Dept. of Nuclear Medicine University of Pécs

Components of Preparedness

Section XII Nuclear Radiology

Procedure Guidelines. Nuclear Medicine

2010 Radiology Prior Authorization List for UnitedHealthcare s HealthChoice Members

Radio-isotopes in Clinical Medicine

Nuclear medicine studies of the digestiv system. Zámbó Katalin Department of Nuclear Medicine

Nuclear Oncology Applications

Description MRI, TMJ C T Head Without Contrast C T Head With Contrast C T Head Without & With Contrast

Nuclear Medicine Technique I

From 2015/2016 Batch

Radionuclide & Radiopharmaceuticals

NM-GGC-PROC-006 Nuclear Medicine Referral Criteria. NHS Greater Glasgow and Clyde

Nuclear Medicine in Oncology

weighing risks against benefits ALARA principle appropriate activities (radiopharmaceutical doses)

Nuclear medicine in gastrointestinal system. Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD A. Barić, MD, nucl. med. spec.

Florida Hospital Diagnostic Radiology Residency Nuclear Medicine Goals and Objectives Training Location: Orlando

Malignant Cardiac Tumors Rad-Path Correlation

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

Nuclear Medicine Diagnosis

Radiopharmacy. Prof. Dr. Çetin ÖNSEL. CTF Nükleer Tıp Anabilim Dalı

Hybrid Imaging SPECT/CT PET/CT PET/MRI. SNMMI Southwest Chapter Aaron C. Jessop, MD

Clinical Trials? John Buscombe

EXPOSURE FROM DIAGNOSTIC NUCLEAR MEDICINE PROCEDURES. 14 Victor Babes Street, RO-6600, Iasi, Romania

Nuclear medicine in renal scarring

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique

Gastrointestinal tract

PATIENT DOSES DUE TO DIAGNOSTIC NUCLEAR MEDICINE EXAMINATIONS IN LITHUANIA

Outline. Lifetime Attributable Risk 10 mgy in 100,000 exposed persons (BEIR VII 2006) SPECT/CT and PET/CT Dosimetry

THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE

Chapter 19: Radionuclide Therapy

Austin Radiological Association Nuclear Medicine Procedure THERAPY FOR THYROID CANCER (I-131 as Sodium Iodide)

Paediatrics. John Buscombe

PHARMACEUTICALS IN MEDICAL IMAGING

Case 4: Disseminated bone metastases from differentiated follicular thyroid cancer

NUCLEAR MEDICINE APC TASK FORCE

COURSE OUTLINE Pathophysiology

SCINTIGRAPHY OF THE CENTRAL NERVOUS SYSTEM Part 1: Introduction and BBB studies

Nuclear medicine in oncology. 1. Diagnosis 2. Therapy

Nuclear Medicine Ordering Guide

Tumor Imaging in Nuclear Medicine: Current Status and

Nuclear medicine in endocrinology

Medical imaging X-ray, CT, MRI, scintigraphy, SPECT, PET Györgyi Műzes

Itroduction to the Nuclear Medicine: biophysics and basic principles. Zámbó Katalin Department of Nuclear Medicine

The Role of SPECT/ PET

Last Updated: 2/10/2017 Implementation date: 4/3/2017 Radiology & Cardiology Prior Authorization / Utilization Management Procedure List

Dose reduction has been a work in progress in pediatric

A Doctor's Guide to Nuclear Medicine

Population Collective Effective Dose from Nuclear Medicine procedures in Greece

Le FDG dans l évaluation de la viabilité : Quelle place par rapport aux autres traceurs?

TW Hamilton, EP Ficaro, TA Mitchell, JN Kritzman, JR Corbett University of Michigan Health System, Ann Arbor, MI

73725x2 MRA Pelvis Runoff (to ankle) CTA Abdomen with & without CTA Cardiac Brain without 70551

Parathyroid Imaging What is best

Indium-111 Zevalin Imaging

Part 7: Regulatory Issues and Quality Control. Part 1: Current NRC Regulations Related to Radiation Safety

NEW ASPECTS OF RADIONUCLIDE THERAPY OF BONE AND JOINT DISEASES

A 64 y.o. man presents to the hospital with persistent cough and hemoptysis. Fernando Mut Montevideo - Uruguay

PRODUCT CATALOGUE. A complete palette in Nuclear Medicine. Oncology. Cardiology. Neurology

Nuclear Cardiology Reimbursement. Todd Lamb, BS, AS, CNMT Clinical Operations Mgr Regions Hospital St. Paul, MN

Nuclear Medicine in the Diabetic Foot

Click here for Link to References: CMS Website HOPPS CY 2018 Final Rule. CMS Website HOPPS CY2018 Final Rule Updated November 2017.

AN INTRODUCTION TO NUCLEAR MEDICINE

RADIOMETABOLIC THERAPY!!

Updated version

Austin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP)

Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs)

Imaging in Pediatric Thyroid disorders: US and Radionuclide imaging. Deepa R Biyyam, MD Attending Pediatric Radiologist

Nuclear medicine in oncology. 1. Diagnosis 2. Therapy

Establishment of Dose Reference Levels for Nuclear Medicine in Sudan

MEDICAL FACULTY DEPARTMENT OF PATHOPHYSIOLOGY QUESTION FOR ORAL PART OF EXAM MEDICAL STUDENTS

New Horizons in radionuclide therapy. John Buscombe Royal Free Hospital

Content Manual American Board of Nuclear Medicine

NUCLEAR CARDIOLOGY UPDATE

15 Annex - Energy 81. RULEBOOK ON APPLICATION OF IONISING RADIATION SOURCES IN MEDICINE

RADIONUCLIDE THERAPY FOR PALLIATION OF PAIN FROM BONY METASTASES

Transcription:

approved and issued by a noted Authorized User on your Materials License. CENTRAL NERVOUS SYSTEM Brain Metabolism Brain Perfusion Cisternography Ventricular Shunt 18 F-FDG 10-20 mci (370 740 MBq) 99m Tc ECD 20 mci (740 MBq) 99m Tc HMPAO 20 mci (740 MBq) 111 In DTPA 1.5 mci (55.5 MBq) 99m Tc DTPA 1 mci (30 MBq) CARDIOVASCULAR SYSTEM Angiography Brain & Peripheral Cardiac Blood Pool Rest Lymphoscintrigraphy Myocardial Perfusion Myocardial Perfusion 99m Tc DTPA 25 mci (925 MBq) 99m Tc RBC 25 mci (925 MBq) 99m Tc SC Filtered (0.1-0.2μ) 0.5-1 mci (18.5 37 MBq) 13 N Ammonia 20 mci (740 MBq) 82 Rb Chloride 50 60 mci (1.85 2.22 GBq) Myocardial Perfusion 99m Tc Tetrofosmin 99m Tc Sestamibi 15 / 30 mci (0.555 1.11 GBq) 15 / 30 mci (0.555 1.11 GBq) Myocardial Viability Perfusion & Viability 18 F FDG 10 20 mci (370 740 MBq) 201 Tl Chloride 1.5 / 3.0 mci (55.5 111 MBq) ENDOCRINE Neuroectodermal / Norepinephrine 123 I MIBG 10 mci (370 MBq) 131 I MIBG 1 mci (37 MBq) Parathyroid 99m Tc Sestamibi 25 mci (925 MBq) MPC 2008 1

ENDOCRINE Cont d. Thyroid Imaging Thyroid Imaging Thyroid Metastases 123 I 0.5 mci (18.5 MBq) 99m Tc 5 mci (185 MBq) 123 I 2 mci (74 MBq) 131 I 2 10 mci (74 370 MBq) Thyroid Uptake 123 I 0.1 mci (3.7 MBq) 131 I 0.01 mci (0.37 MBq) GASTROINSTESTINAL Esophageal Transit 99m Tc SC in H 2 O 0.3 mci/15 ml (11.1 MBq) Gastric Emptying 99m Tc SC in Oatmeal 1 mci/pkg (37 MBq) Gastro-Esophageal Reflux 99m Tc SC in Orange Juice 0.3 mci/300 ml (11.1 MBq) Gastrointestinal Bleeding H.Pylori Breath Test Hepatic Artery Perfusion Hepatic Hemangioma Hepato Biliary LeVeen Shunt 99m Tc RBC 25 mci (925 MBq) 14 C Urea 0.001 mci (0.037 MBq) 99m Tc MAA 3 mci (111 MBq) 99m Tc RBC 25 mci (925 MBq) 99m Tc IDA 6 mci (222 MBq) 99m Tc MAA 5 mci (185 MBq) 99m Tc SC 3 mci (111 MBq) Liver Spleen Meckels Diverticulum 99m Tc SC 6 mci (222 MBq) 99m Tc 5 mci (185 MBq) MPC 2008 2

GENTOURINARY Cystogram 99m Tc 1 mci (37 MBq) 99m Tc SC 1 mci (37 MBq) 99m Tc DTPA 1 mci (37 MBq) Renal DMSA Renal DTPA Renal MAG3 99m Tc DMSA 5 mci (185 MBq) 99m Tc DTPA 15 mci (555 MBq) 99m Tc MAG3 10 mci (370 MBq) HEMATOLOGY Bone Marrow Schilling s Test 99m Tc SC 15 mci (555 MBq) 57 Co Vitamin B-12 0.5 1 mci (18.5 37 MBq) INFECTION Gallium WBC Activation 67 Ga Citrate 6 10 mci (222 370 MBq) 18 F FDG 10 20 mci (370-740 MBq) WBC Migration Study 99m Tc WBC HMPAO 10 25 mci (370 925 MBq) 111 In WBC 0.5 mci (18.5 MBq) PULMONARY Lung Aerosol 99m Tc DTPA Aerosol 6 mci to Pt. (222 MBq) 50-75 mci to Nebulizer (1.85 2.77 GBq) Lung Perfusion Lung Ventilation 99m Tc MAA 6 mci / Xe-133 (222 MBq) 2 mci / before aerosol (74 MBq) 133 Xe Gas 20 mci (740 MBq) MPC 2008 3

PULMONARY cont d. Pulmonary Aspiration 99m Tc SC 0.5 mci / 300 ml Formula 2 mci / 300 ml H 2 O SKELETAL Skeletal F-18 Bone Mineral Study 18 F Chloride 10-20 mci (370 740 MBq) 99m Tc MDP 25 mci (925 MBq) 99m Tc HMDP 25 mci (925 MBq) TUMOR B-Cell Lymphoma Bexxar 131 I Tositumomab 5 mci (185 MBq) B-Cell Lymphoma-Zevalin 111 In Ibritumomab Tiuxetan 5 mci (185 MBq) Prostate Ca Study Neuroendocrine Tumor 111 In Capromab Pendetide 5 mci (185 MBq) 111 In Pentetreotide 6 mci (222 MBq) Tumor Glucose Metabolism 18 F FDG 10-20 mci (370 740 MBq) Tumor Viability 201 Tl Chloride 5 mci (185 MBq) 99m Tc Sestamibi 25 mci (925 MBq) 99m Tc Tetrofosmin 25 mci (925 MBq) MPC 2008 4

ENDOCRINE Thyroid Cancer Papillo-follicular 131 I Residual Functioning Tissue Post Thyroidectomy 70 150 mci (2.59 5.55 GBq) 131 I Persistent or Recurrent Functioning Thyroid Ca 100 200 mci (3.7 7.4 GBq) Thyroid Cancer Compressive Goiter 131 I 100 mci (3.7 GBq) Diffuse Hyperthyroidism Nodular Hyperthyroidism 131 I 10 20 mci (370 740 MBq) 131 I 15 35 mci (0.555 1.3 GBq) HEMATOLOGIC Polycythemia Vera 32 P Sodium Solution 2.3 mci/m 2 (85.1 MBq / m 2 ) INTRACAVITARY Fluid or Neoplasm 32 P Chromic Colloid Pleura 10 15 mci Peritoneum 15-20 mci Pericardium 5-10 mci SKELETAL Osseous Metastases Pain 89 Sr Chloride 0.04 0.06 mci / kg 153 Sm EDTMP 1.0 mci / kg Synoviorthesis 32 P Chromic Colloid Knee 1 mci (37 MBq) Elbow 0.5 mci (18.5 MBq) MPC 2008 5

TUMOR B-Cell Lymphoma 90 Y Zevalin 0.4 mci / kg ** (>150,000 platelets/ml) 0.3 mci / kg ** (100K 150K platelets/ml) ** Not to Exceed 32 mci B-Cell Lymphoma 131 I Bexxar MPC 2008 6